These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17014950)

  • 61. Long-term efficacy of duloxetine in women with stress urinary incontinence.
    Bump RC; Voss S; Beardsworth A; Manning M; Zhao YD; Chen W
    BJU Int; 2008 Jul; 102(2):214-8. PubMed ID: 18422764
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of duloxetine on quality of life for women with symptoms of urinary incontinence.
    Kinchen KS; Obenchain R; Swindle R
    Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(5):337-44. PubMed ID: 15662490
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of Duloxetine for Postprostatectomy Stress Urinary Incontinence: A Systematic Review.
    Kotecha P; Sahai A; Malde S
    Eur Urol Focus; 2021 May; 7(3):618-628. PubMed ID: 32605820
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Duloxetine in the treatment of urinary incontinence in women].
    Lello S; Paoletti AM; Guardianelli F; Floris S; Melis M; Melis GB
    Minerva Ginecol; 2004 Aug; 56(4):349-52. PubMed ID: 15377983
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Duloxetine: new drug. For stress urinary incontinence: too much risk, too little benefit.
    Prescrire Int; 2005 Dec; 14(80):218-20. PubMed ID: 16400743
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence.
    Tsakiris P; de la Rosette JJ; Michel MC; Oelke M
    Eur Urol; 2008 Jan; 53(1):53-9. PubMed ID: 17920183
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacologic treatment in postprostatectomy stress urinary incontinence.
    Filocamo MT; Li Marzi V; Del Popolo G; Cecconi F; Villari D; Marzocco M; Nicita G
    Eur Urol; 2007 Jun; 51(6):1559-64. PubMed ID: 16942833
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Urinary incontinence: pharmacotherapy options.
    Smith AL; Wein AJ
    Ann Med; 2011; 43(6):461-76. PubMed ID: 21639723
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Postprostatectomy established stress urinary incontinence treated with duloxetine.
    Collado Serra A; Rubio-Briones J; Puyol Payás M; Iborra Juan I; Ramón-Borja JC; Solsona Narbón E
    Urology; 2011 Aug; 78(2):261-6. PubMed ID: 21601255
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The 10-minute consultation. Urinary incontinence in a woman].
    Kolben M; Maurer S; Knitza R
    MMW Fortschr Med; 2004 Jul; 146(29-30):59-60. PubMed ID: 15540565
    [No Abstract]   [Full Text] [Related]  

  • 71. Tolerability of amine uptake inhibitors in urologic diseases.
    Michel MC; Ruhe HG; de Groot AA; Castro R; Oelke M
    Curr Drug Saf; 2006 Jan; 1(1):73-85. PubMed ID: 18690917
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mid-urethral sling operations for stress urinary incontinence in women.
    Ford AA; Rogerson L; Cody JD; Aluko P; Ogah JA
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006375. PubMed ID: 28756647
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence.
    Fraser MO; Chancellor MB
    BJU Int; 2003 May; 91(8):743-8. PubMed ID: 12709086
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mid-urethral sling operations for stress urinary incontinence in women.
    Ford AA; Rogerson L; Cody JD; Ogah J
    Cochrane Database Syst Rev; 2015 Jul; (7):CD006375. PubMed ID: 26130017
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An overview of stress urinary incontinence treatment in women.
    Papatsoris AG; Chrisofos M; Antoniou N; Gekas A; Deliveliotis C
    Aging Clin Exp Res; 2007 Aug; 19(4):334-40. PubMed ID: 17726366
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mixed incontinence: current evidence and future perspectives.
    Khullar V; Cardozo L; Dmochowski R
    Neurourol Urodyn; 2010 Apr; 29(4):618-22. PubMed ID: 20432324
    [TBL] [Abstract][Full Text] [Related]  

  • 78. What do we know about duloxetine's mode of action? Evidence from animals to humans.
    Schuessler B
    BJOG; 2006 May; 113 Suppl 1():5-9. PubMed ID: 16529563
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine.
    Thor KB; Kirby M; Viktrup L
    Int J Clin Pract; 2007 Aug; 61(8):1349-55. PubMed ID: 17608681
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Stress urinary incontinence in women--current treatment alternatives].
    Schiøtz HA
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1773-6. PubMed ID: 17599125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.